{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:10:11Z","timestamp":1791299411416,"version":"4.1.0"},"reference-count":43,"publisher":"Norwegian Medical Association","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"published-print":{"date-parts":[[2012,4,30]]},"DOI":"10.4045\/tidsskr.10.0872","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T04:51:04Z","timestamp":1336366264000},"page":"970-3","source":"Crossref","is-referenced-by-count":54,"title":["Spasticity following spinal cord injury"],"prefix":"10.4045","volume":"132","author":[{"given":"Tiina","family":"Rekand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen Merete","family":"Hagen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marit","family":"Gr\u00f8nning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Johnson RL, Gerhart KA, McCray J et al. Secondary conditions following spinal cord injury in a\u00a0population-based sample. Spinal Cord 1998; 36: 45\u2009\u2013\u200950. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=9471138&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/sj.sc.3100494","DOI":"10.1038\/sj.sc.3100494"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Noreau L, Proulx P, Gagnon L et al. Secondary impairments after spinal cord injury: a population-based study. Am J Phys Med Rehabil 2000; 79: 526\u2009\u2013\u200935. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11083303&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/00002060-200011000-00009","DOI":"10.1097\/00002060-200011000-00009"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Levi R, Hultling C, Nash MS et al. The Stockholm spinal cord injury study: 1. Medical problems in a\u00a0regional SCI population. Paraplegia 1995; 33: 308\u2009\u2013\u200915. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7644255&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/sc.1995.70","DOI":"10.1038\/sc.1995.70"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Sk\u00f6ld C, Levi R, Seiger \u00c5. Spasticity after traumatic spinal cord injury: nature, severity, and location. Arch Phys Med Rehabil 1999; 80: 1548\u2009\u2013\u200957. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10597805&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0003-9993(99)90329-5","DOI":"10.1016\/S0003-9993(99)90329-5"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Lance JW. The control of muscle tone, reflexes, and movement: Robert Wartenberg Lecture. Neurology 1980; 30: 1303\u2009\u2013\u200913. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7192811&dopt=Abstract","DOI":"10.1212\/WNL.30.12.1303"},{"key":"ref=6","doi-asserted-by":"crossref","unstructured":"Stevenson VL. Rehabilitation in practice: Spasticity management. Clin Rehabil 2010; 24: 293\u2009\u2013\u2009304. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20360150&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177\/0269215509353254","DOI":"10.1177\/0269215509353254"},{"key":"ref=7","doi-asserted-by":"crossref","unstructured":"Ward AB. Spasticity treatment with botulinum toxins. J Neural Transm 2008; 115: 607\u2009\u2013\u200916. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18389166&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00702-007-0833-2","DOI":"10.1007\/s00702-007-0833-2"},{"key":"ref=8","doi-asserted-by":"crossref","unstructured":"Elbasiouny SM, Moroz D, Bakr MM et al. Management of spasticity after spinal cord injury: current techniques and future directions. Neurorehabil Neural Repair 2010; 24: 23\u2009\u2013\u200933. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19723923&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177\/1545968309343213","DOI":"10.1177\/1545968309343213"},{"key":"ref=9","doi-asserted-by":"crossref","unstructured":"Saval A, Chiodo AE. Intrathecal baclofen for spasticity management: a comparative analysis of spasticity of spinal vs cortical origin. J Spinal Cord Med 2010; 33: 16\u2009\u2013\u200921. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20397440&dopt=Abstract","DOI":"10.1080\/10790268.2010.11689670"},{"key":"ref=10","doi-asserted-by":"crossref","unstructured":"Gracies J-M. Pathophysiology of spastic paresis. I:\u00a0Paresis and soft tissue changes. Muscle Nerve 2005; 31: 535\u2009\u2013\u200951. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15714510&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/mus.20284","DOI":"10.1002\/mus.20284"},{"key":"ref=11","doi-asserted-by":"crossref","unstructured":"Gracies J-M. Pathophysiology of spastic paresis. II:\u00a0Emergence of muscle overactivity. Muscle Nerve 2005; 31: 552\u2009\u2013\u200971. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15714511&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002\/mus.20285","DOI":"10.1002\/mus.20285"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Adams MM, Hicks AL. Spasticity after spinal cord injury. Spinal Cord 2005; 43: 577\u2009\u2013\u200986. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15838527&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038\/sj.sc.3101757","DOI":"10.1038\/sj.sc.3101757"},{"key":"ref=13","doi-asserted-by":"crossref","unstructured":"Green D, Hartwig D, Chen D et al. Spinal Cord Injury Risk Assessment for Thromboembolism (SPIRATE Study). Am J Phys Med Rehabil 2003; 82: 950\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14627932&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/01.PHM.0000098043.88979.BA","DOI":"10.1097\/01.PHM.0000098043.88979.BA"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Murphy NA. Deep venous thrombosis as a result of hypotonia secondary to intrathecal baclofen therapy: a case report. Arch Phys Med Rehabil 2002; 83: 1311\u2009\u2013\u20092. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12235615&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1053\/apmr.2002.34270","DOI":"10.1053\/apmr.2002.34270"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Yelnik AP, Simon O, Parratte B et al. How to clinically assess and treat muscle overactivity in spastic paresis. J Rehabil Med 2010; 42: 801\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20878038&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2340\/16501977-0613","DOI":"10.2340\/16501977-0613"},{"key":"ref=16","doi-asserted-by":"crossref","unstructured":"Lechner HE, Frotzler A, Eser P. Relationship between self- and clinically rated spasticity in spinal cord injury. Arch Phys Med Rehabil 2006; 87: 15\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16401432&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.apmr.2005.07.312","DOI":"10.1016\/j.apmr.2005.07.312"},{"key":"ref=17","unstructured":"Ashworth B. Preliminary trial of carisopodol in multiple sclerosis. Practitioner 1964; 192: 540\u2009\u2013\u20092."},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"Fleuren JF, Voerman GE, Erren-Wolters CV et al. Stop using the Ashworth Scale for the assessment of spasticity. J Neurol Neurosurg Psychiatry 2010; 81: 46\u2009\u2013\u200952. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19770162&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136\/jnnp.2009.177071","DOI":"10.1136\/jnnp.2009.177071"},{"key":"ref=19","unstructured":"Tardieu G, Shentoub S, Delarue R. A la recherch\u00e9 d\u2019une technique de mesure de la spasticit\u00e9. Rev Neurol 1954; 91: 143\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=14358132&dopt=Abstract"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Mehrholz J, Wagner K, Meissner D et al. Reliability of the Modified Tardieu Scale and the Modified Ashworth Scale in adult patients with severe brain injury: a comparison study. Clin Rehabil 2005; 19: 751\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16250194&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1191\/0269215505cr889oa","DOI":"10.1191\/0269215505cr889oa"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Penn RD, Savoy SM, Corcos D et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med 1989; 320: 1517\u2009\u2013\u200921. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2657424&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1056\/NEJM198906083202303","DOI":"10.1056\/NEJM198906083202303"},{"key":"ref=22","doi-asserted-by":"crossref","unstructured":"Priebe MM, Sherwood AM, Thornby JI et al. Clinical assessment of spasticity in spinal cord injury: a multidimensional problem. Arch Phys Med Rehabil 1996; 77: 713\u2009\u2013\u20096. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8670001&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/S0003-9993(96)90014-3","DOI":"10.1016\/S0003-9993(96)90014-3"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Gracies JM. Pathophysiology of impairment in patients with spasticity and use of stretch as a\u00a0treatment of spastic hypertonia. Phys Med Rehabil Clin N Am 2001; 12: 747\u2009\u2013\u200968. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11723864&dopt=Abstract","DOI":"10.1016\/S1047-9651(18)30031-7"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Kita M, Goodkin DE. Drugs used to treat spasticity. Drugs 2000; 59: 487\u2009\u2013\u200995. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10776831&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/00003495-200059030-00006","DOI":"10.2165\/00003495-200059030-00006"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Hinderer SR, Lehmann JF, Price R et al. Spasticity in spinal cord injured persons: quantitative effects of baclofen and placebo treatments. Am J Phys Med Rehabil 1990; 69: 311\u2009\u2013\u20097 PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=2264951&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/00002060-199012000-00007","DOI":"10.1097\/00002060-199012000-00007"},{"key":"ref=26","unstructured":"Burke D, Gillies JD, Lance JW. An objective assessment of a gamma aminobutyric acid derivative in the control of spasticity. Proc Aust Assoc Neurol 1971; 8: 131\u2009\u2013\u20094. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=4949207&dopt=Abstract"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Dario A, Tomei G. A benefit-risk assessment of baclofen in severe spinal spasticity. Drug Saf 2004; 27: 799\u2009\u2013\u2009818. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15350152&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/00002018-200427110-00004","DOI":"10.2165\/00002018-200427110-00004"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Milanov I, Georgiev D. Mechanisms of tizanidine action on spasticity. Acta Neurol Scand 1994; 89: 274\u2009\u2013\u20099. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8042446&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1600-0404.1994.tb01680.x","DOI":"10.1111\/j.1600-0404.1994.tb01680.x"},{"key":"ref=29","unstructured":"Nance PW, Bugaresti J, Shellenberger K et al. Efficacy and safety of tizanidine in the treatment of spasticity in patients with spinal cord injury. Neurology 1994; 44 (suppl 9): S44\u2009\u2013\u200951. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7970010&dopt=Abstract"},{"key":"ref=30","unstructured":"Taricco M, Pagliacci MC, Telaro E et al. Pharmacological interventions for spasticity following spinal cord injury: results of a Cochrane systematic review. Eura Medicophys 2006; 42: 5\u2009\u2013\u200915. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16565680&dopt=Abstract"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Karst M, Wippermann S, Ahrens J. Role of cannabinoids in the treatment of pain and (painful) spasticity. Drugs 2010; 70: 2409\u2009\u2013\u200938. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21142261&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2165\/11585260-000000000-00000","DOI":"10.2165\/11585260-000000000-00000"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"M\u00fcller K, Mix E, Adib Saberi F et al. Prevalence of neutralising antibodies in patients treated with botulinum toxin type A for spasticity. J Neural Transm 2009; 116: 579\u2009\u2013\u200985. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19352590&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007\/s00702-009-0223-z","DOI":"10.1007\/s00702-009-0223-z"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Wissel J, Ward AB, Erztgaard P et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 2009; 41: 13\u2009\u2013\u200925. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19197564&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.2340\/16501977-0303","DOI":"10.2340\/16501977-0303"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Giovannelli M, Borriello G, Castri P et al. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil 2007; 21: 331\u2009\u2013\u20097. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17613573&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177\/0269215507072772","DOI":"10.1177\/0269215507072772"},{"key":"ref=35","unstructured":"Smedal T, Gjelsvik B, Lygren H et al. Botulinum toksin A- effekt p\u00e5 spastisitet. Tidsskr Nor L\u00e6geforen 2001; 121: 3277-80. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11826458&dopt=Abstract"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Naumann M, Albanese A, Heinen F et al. Safety and efficacy of botulinum toxin type A following long-term use. Eur J Neurol 2006; 13 (suppl 4): 35\u2009\u2013\u200940. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17112348&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111\/j.1468-1331.2006.01652.x","DOI":"10.1111\/j.1468-1331.2006.01652.x"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Marciniak C, Rader L, Gagnon C. The use of botulinum toxin for spasticity after spinal cord injury. Am J Phys Med Rehabil 2008; 87: 312\u2009\u2013\u20097, quiz 318\u2009\u2013\u200920, 329. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18356622&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097\/PHM.0b013e318168ceaf","DOI":"10.1097\/PHM.0b013e318168ceaf"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Coffey JR, Cahill D, Steers W et al. Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 1993; 78: 226\u2009\u2013\u200932. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=8421205&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.3171\/jns.1993.78.2.0226","DOI":"10.3171\/jns.1993.78.2.0226"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Koulousakis A, Kuchta J. Intrathecal antispastic drug application with implantable pumps: results of a 10 years follow-up study. Acta Neurochir Suppl (Wien) 2007; 97: 181\u2009\u2013\u20094. Crossref: http:\/\/dx.doi.org\/10.1007\/978-3-211-33079-1_24","DOI":"10.1007\/978-3-211-33079-1_24"},{"key":"ref=40","doi-asserted-by":"crossref","unstructured":"Guillaume D, Van Havenbergh A, Vloeberghs M et al. A clinical study of intrathecal baclofen using a\u00a0programmable pump for intractable spasticity. Arch Phys Med Rehabil 2005; 86: 2165\u2009\u2013\u200971. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=16271565&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.apmr.2005.05.018","DOI":"10.1016\/j.apmr.2005.05.018"},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Lynn AK, Turner M, Chambers HG. Surgical management of spasticity in persons with cerebral palsy. PM R 2009; 1: 834\u2009\u2013\u20098. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19769917&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016\/j.pmrj.2009.07.016","DOI":"10.1016\/j.pmrj.2009.07.016"},{"key":"ref=42","doi-asserted-by":"crossref","unstructured":"Smyth MD, Peacock WJ. The surgical treatment of spasticity. Muscle Nerve 2000; 23: 153\u2009\u2013\u200963. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=10639605&dopt=Abstract","DOI":"10.1002\/(SICI)1097-4598(200002)23:2<153::AID-MUS3>3.0.CO;2-4"},{"key":"ref=43","unstructured":"Gr\u00f8nning M, Svendsen F, Skeidsvoll H et al.  Spastisitet behandlet med selektiv bakre rhizotomi. Tidsskr Nor L\u00e6geforen 2002; 122: 1190-1. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12089845&dopt=Abstract"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Spastisitet etter ryggmargsskade"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:18:47Z","timestamp":1781655527000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2012\/04\/oversiktsartikkel\/spastisitet-etter-ryggmargsskade"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,30]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,4,30]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.10.0872","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,30]]}}}